Peroxisome proliferator–activated receptor γ agonists for the Prevention of Adverse events following percutaneous coronary Revascularization—results of the PPAR Study

Bhatt, Deepak L.; Chew, Derek P.; Grines, Cindy; Mukherjee, Debabrata; Leesar, Massoud; Gilchrist, Ian C.; Corbelli, John C.; Blankenship, James C.; Eres, Avichai; Steinhubl, Steven; Tan, Walter A.; Resar, Jon R.; AlMahameed, Amjad; Abdel-Latif, Ahmed; Tang, H. Wilson; Brennan, Danielle; McErlean, Ellen; Hazen, Stanley L.; Topol, Eric J.

doi:10.1016/j.ahj.2007.03.029

« Previous Next »American Heart Journal
Volume 154, Issue 1 , Pages 137-143, July 2007

Peroxisome proliferator–activated receptor γ agonists for the Prevention of Adverse events following percutaneous coronary Revascularization—results of the PPAR Study

Deepak L. Bhatt, MD
- Cleveland Clinic, Cleveland, OH
- Reprint requests: Deepak L. Bhatt MD, FACC, FSCAI, FESC, FACP, Cleveland Clinic, Department of Cardiovascular Medicine, 9500 Euclid Avenue, Desk F25, Cleveland, OH 44195.
Derek P. Chew, MBBS, MPH
- Flinders Medical Centre, Adelaide, Australia
Cindy Grines, MD
- William Beaumont Hospital, Royal Oak, MI
Debabrata Mukherjee, MBBS
- University of Kentucky, Louisville, KY
Massoud Leesar, MD
- University of Louisville, Louisville, KY
Ian C. Gilchrist, MD
- Hershey Medical Center, Hershey, PA
John C. Corbelli, MD
- Millard Fillmore Hospital, Buffalo, NY
James C. Blankenship, MD
- Geisinger Medical Center, Danville, PA
Avichai Eres, MD
- Central Baptist Hospital, Lexington, KY
Steven Steinhubl, MD
- University of Kentucky, Louisville, KY
Walter A. Tan, MD, MS
- The University of North Carolina at Chapel Hill, Chapel Hill, NC
Jon R. Resar, MD
- Johns Hopkins Hospital, Baltimore, MD
Amjad AlMahameed, MD, MPH
- Cleveland Clinic, Cleveland, OH
Ahmed Abdel-Latif, MD
- Cleveland Clinic, Cleveland, OH
H. Wilson Tang, MD
- Cleveland Clinic, Cleveland, OH
Danielle Brennan, MS
- Cleveland Clinic, Cleveland, OH
Ellen McErlean, MSN, RN
- Cleveland Clinic, Cleveland, OH
Stanley L. Hazen, MD, PhD
- Cleveland Clinic, Cleveland, OH
Eric J. Topol, MD
- Case Western Reserve University, Cleveland, OH

Received 1 January 2007; accepted 19 March 2007. published online 01 May 2007.

Dr Bhatt reports having received honoraria for consulting on scientific advisory boards from Astra Zeneca, Bristol Myers Squibb, Cardax, Centocor, Daiichi-Sankyo, Eisai, Eli Lilly, GlaxoSmithKline, Millennium, Otsuka, Paringenix, PDL, Sanofi Aventis, Schering Plough, The Medicines Company, TNS Healthcare—all such honoraria are currently donated to nonprofit organizations. Dr Tang has served on the speakers' bureau for Takeda Pharmaceuticals and is a consultant to Amylin Pharmaceuticals, GlaxoSmithKline Pharmaceuticals, Philadelphia, PA, and F-Hoffman La Roche, Inc. The other authors did not report any disclosures.